VitaSpring Biomedical Co. Ltd.
VSBC
$1.00
$0.000.00%
OTC PK
| 10/31/2022 | 07/31/2022 | 04/30/2022 | 01/31/2022 | 10/31/2021 | |
|---|---|---|---|---|---|
| Net Income | 935.70K | 970.80K | 1.31M | 1.26M | -23.00K |
| Total Depreciation and Amortization | 15.20K | 15.20K | 12.20K | 8.40K | 4.60K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 492.70K | 472.90K | 606.40K | 477.40K | 526.80K |
| Change in Net Operating Assets | -1.68M | -2.08M | -2.23M | -1.66M | -309.40K |
| Cash from Operations | -240.00K | -619.30K | -302.10K | 84.90K | 198.80K |
| Capital Expenditure | 0.00 | -23.20K | -73.00K | -73.00K | -73.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 0.00 | -23.20K | -73.00K | -73.00K | -73.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 50.00K | 50.00K | 50.00K | 50.00K | 91.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -3.50K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 50.00K | 50.00K | 50.00K | 50.00K | 87.50K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -190.00K | -592.50K | -325.10K | 61.90K | 213.40K |